Torsade de pointes associated with rupatadine.
Fité-Mora
Ramon
R
D003533:Cyproheptadine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced / Q000503:physiopathology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D011358:Product Surveillance, Postmarketing; D016032:Randomized Controlled Trials as Topic; D013030:Spain; D016171:Torsades de Pointes / Q000139:chemically induced*
D006634:Histamine H1 Antagonists; D010972:Platelet Activating Factor; C103639:rupatadine; D003533:Cyproheptadine